Pharmaceutical Investing Johnson & Johnson to Expand Neuroscience Portfolio with US$14.6 Billion Acquisition
Pharmaceutical Investing InhaleRx Pens AU$38.5 Million Funding Agreement with Clendon Biotech Capital